Pre-made Orticumab benchmark antibody ( Whole mAb, anti-OxLDL therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-412

Pre-Made Orticumab biosimilar, Whole Mab: Anti-OxLDL therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-412-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg


Products Name (INN Index) Pre-Made Orticumab biosimilar, Whole Mab: Anti-OxLDL therapeutic antibody
INN Name Orticumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCLambda
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2012
Year Recommended2013
CompaniesAbcentra;BioInvent International;Genentech
Conditions Approvedna
Conditions ActiveAtherosclerosis;Psoriasis
Conditions Discontinuedna
Development TechHuman Phage Display